- Home
- ACON vs EVOK Comparison
ACON vs EVOK Comparison
Compare ACON & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- EVOK
- Stock Information
- Founded
- ACON 2008
- EVOK 2007
- Country
- ACON United States
- EVOK United States
- Employees
- ACON N/A
- EVOK N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- EVOK Health Care
- Exchange
- ACON Nasdaq
- EVOK Nasdaq
- Market Cap
- ACON 4.8M
- EVOK 4.2M
- IPO Year
- ACON 2022
- EVOK 2013
- Fundamental
- Price
- ACON $7.64
- EVOK $2.59
- Analyst Decision
- ACON Buy
- EVOK
- Analyst Count
- ACON 2
- EVOK 0
- Target Price
- ACON $481.00
- EVOK N/A
- AVG Volume (30 Days)
- ACON 75.1K
- EVOK 16.5K
- Earning Date
- ACON 04-09-2025
- EVOK 05-13-2025
- Dividend Yield
- ACON N/A
- EVOK N/A
- EPS Growth
- ACON N/A
- EVOK N/A
- EPS
- ACON N/A
- EVOK N/A
- Revenue
- ACON $45,724.00
- EVOK $10,249,415.00
- Revenue This Year
- ACON $251.35
- EVOK $58.84
- Revenue Next Year
- ACON N/A
- EVOK $58.11
- P/E Ratio
- ACON N/A
- EVOK N/A
- Revenue Growth
- ACON N/A
- EVOK 97.84
- 52 Week Low
- ACON $7.26
- EVOK $1.94
- 52 Week High
- ACON $6,241.05
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- ACON 33.40
- EVOK 47.70
- Support Level
- ACON $8.15
- EVOK $2.02
- Resistance Level
- ACON $8.30
- EVOK $2.53
- Average True Range (ATR)
- ACON 1.25
- EVOK 0.22
- MACD
- ACON 6.41
- EVOK 0.10
- Stochastic Oscillator
- ACON 6.94
- EVOK 97.01
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.